Novel TIE-2 inhibitor BAY-826 displays in vivo efficacy in experimental syngeneic murine glioma models.
about
Novel TIE-2 inhibitor BAY-826 displays in vivo efficacy in experimental syngeneic murine glioma models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel TIE-2 inhibitor BAY-826 ...... yngeneic murine glioma models.
@en
type
label
Novel TIE-2 inhibitor BAY-826 ...... yngeneic murine glioma models.
@en
prefLabel
Novel TIE-2 inhibitor BAY-826 ...... yngeneic murine glioma models.
@en
P2093
P2860
P356
P1476
Novel TIE-2 inhibitor BAY-826 ...... yngeneic murine glioma models.
@en
P2093
Alexander Walter
Angela Broggini-Tenzer
Dieter Heldmann
Emese Szabo
Frank Süssmeier
Hannah Schneider
Mario Lobell
Raquel A C Machado
Sylvia Grünewald
P2860
P304
P356
10.1111/JNC.13877
P407
P577
2016-10-27T00:00:00Z